MYCN and neuroblastoma: Given that deregulated MYCN expression is known to dominate the active cis-regulatory landscape of MYCN-amplified (MNA) NB tumors (34), we reasoned that focusing on nMNA tumors, which still represent approximatively 50% of HR-NB, may provide us with a better opportunity to identify additional oncogenic factors promoting the most aggressive state of this disease.